D-0623-2017 Class III Terminated

Recalled by Hetero USA Inc — Piscataway, NJ

FDA drug recall D-0623-2017 was initiated by Hetero USA Inc on Jan 7, 2017 and is designated Class III. Reason for recall: Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle. The recall status is terminated (terminated Aug 8, 2017). Affected quantity: 65,664 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 5, 2017
Initiation Date
Jan 7, 2017
Termination Date
Aug 8, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
65,664 bottles

Product description

Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30

Reason for recall

Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.

Distribution pattern

US Nationwide

Code information

Lot # MON16001B, Exp 01/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0623-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0623-2017. Report a data issue: hello@regdatalab.com.